Activities of prolonged administration of vinorelbine or capecitabine oral to increase time to progression in patients with stable disease after the first line treatment with vinorelbine + xeloda. Randomized study clinical phase II.
Phase of Trial: Phase II
Latest Information Update: 24 May 2012
At a glance
- Drugs Capecitabine (Primary) ; Vinorelbine (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 29 Jul 2011 New trial record